Literature DB >> 10941831

Antioxidative capacity in patients with common variable immunodeficiency.

J Reichenbach1, R Schubert, C Schwan, K Müller, H J Böhles, S Zielen.   

Abstract

Highly reactive oxygen species (ROS) are involved in T-cell activation and in the defense against environmental pathogens. An imbalance of ROS generation, detoxifying scavenger enzymes, and molecules with antioxidant capacity could contribute to the increased susceptibility to cancer and infections in severe humoral immunodeficiency. We studied antioxidant status, i.e., plasma antioxidant capacity (TEAC), retinol, alpha-to-copherol, ubiquinol, and the number of activated T cells in 16 patients with common variable immunodeficiency (CVID) compared to age-matched healthy controls. As expected, patients showed significantly increased levels of activated HLA-DR and CD45RO-expressing T cells. Plasma levels of the endogenous ROS scavenger ubiquinol (Q 10) were significantly lower in patients as compared to controls. However, patients showed only slightly reduced levels of TEAC as well as the exogenous antioxidants retinol and alpha-tocopherol. Although no correlation of the number of activated T cells and antioxidant capacity could be demonstrated, an increase in ROS and a diminished reactive oxygen scavenger capacity may be involved in the disease process in patients with common variable immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941831     DOI: 10.1023/a:1006645731813

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  32 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  The effects of vitamin A derivatives on in vitro antibody production by peripheral blood mononuclear cells (PBMC) from normal blood donors and patients with common variable immunodeficiency (CVID).

Authors:  J G Zhang; L Morgan; G P Spickett
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

Review 3.  The essential functions of coenzyme Q.

Authors:  F L Crane; I L Sun; E E Sun
Journal:  Clin Investig       Date:  1993

4.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates.

Authors:  N J Miller; C Rice-Evans; M J Davies; V Gopinathan; A Milner
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

5.  Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion.

Authors:  Y Yamamoto; S Yamashita
Journal:  Biofactors       Date:  1999       Impact factor: 6.113

6.  Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile?

Authors:  A Kontush; S Schippling; T Spranger; U Beisiegel
Journal:  Biofactors       Date:  1999       Impact factor: 6.113

Review 7.  Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection.

Authors:  G Baier-Bitterlich; D Fuchs; H Wachter
Journal:  Biochem Pharmacol       Date:  1997-03-21       Impact factor: 5.858

8.  Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency.

Authors:  J S Jaffe; W Strober; M C Sneller
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

9.  Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress.

Authors:  P Aukrust; A M Svardal; F Müller; B Lunden; R K Berge; S S Frøland
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes.

Authors:  P Aukrust; F Müller; S S Frøland
Journal:  Clin Immunol Immunopathol       Date:  1994-03
View more
  3 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

Review 3.  Coenzyme Q10 and Immune Function: An Overview.

Authors:  David Mantle; Robert A Heaton; Iain P Hargreaves
Journal:  Antioxidants (Basel)       Date:  2021-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.